BIO-TECHNE Corp Revenue by Geography
No Revenue by Geography for TECH on this site yet.
- 2026-06-30: Product and Services $1.19B; Royalty $24.99M; Total revenue $1.22B.
- 2025-06-30: Product and Services $1.20B; Royalty $23.69M; Total revenue $1.22B.
- 2024-06-30: Product and Services $1.14B; Royalty $23.34M; Total revenue $1.16B.
- 2023-06-30: Others Not split by product in the filing$1.14B100.00%; Total revenue $1.14B.
Source checked: the stored Revenue by Geography page for TECH.
Revenue by product
Each year (12 month)
| Fiscal year end | Product and Services | Royalty | Others | Total revenue |
|---|---|---|---|---|
| 2026-06-30 | $1.19B 97.94% | $24.99M 2.06% | $1.22B | |
| 2025-06-30 | $1.20B 98.06% | $23.69M 1.94% | $1.22B | |
| 2024-06-30 | $1.14B 97.99% | $23.34M 2.01% | $1.16B | |
| 2023-06-30 | Not split by product in the filing $1.14B 100.00% | $1.14B | ||
| 2022-06-30 | Not split by product in the filing $1.11B 100.00% | $1.11B | ||
| 2021-06-30 | Not split by product in the filing $931.03M 100.00% | $931.03M | ||
| 2020-06-30 | Not split by product in the filing $738.69M 100.00% | $738.69M | ||
| 2019-06-30 | Not split by product in the filing $714.01M 100.00% | $714.01M | ||
| 2018-06-30 | Not split by product in the filing $642.99M 100.00% | $642.99M | ||
| 2017-06-30 | Not split by product in the filing $563.00M 100.00% | $563.00M | ||
| 2016-06-30 | Not split by product in the filing $499.02M 100.00% | $499.02M | ||
| 2015-06-30 | Not split by product in the filing $452.25M 100.00% | $452.25M | ||
| 2014-06-30 | Not split by product in the filing $357.76M 100.00% | $357.76M | ||
| 2013-06-30 | Not split by product in the filing $310.57M 100.00% | $310.57M | ||
| 2012-06-30 | Not split by product in the filing $314.56M 100.00% | $314.56M | ||
| 2011-06-30 | Not split by product in the filing $289.96M 100.00% | $289.96M | ||
| 2010-06-30 | Not split by product in the filing $269.05M 100.00% | $269.05M | ||
| 2009-06-30 | Not split by product in the filing $263.96M 100.00% | $263.96M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $321.19M 100.00% | $321.19M |
| 2026-03-31 | Not split by product $311.42M 100.00% | $311.42M |
| 2025-12-31 | Not split by product $295.88M 100.00% | $295.88M |
| 2025-09-30 | Not split by product $286.56M 100.00% | $286.56M |
| 2025-06-30 | Not split by product $316.96M 100.00% | $316.96M |
| 2025-03-31 | Not split by product $316.18M 100.00% | $316.18M |
| 2024-12-31 | Not split by product $297.03M 100.00% | $297.03M |
| 2024-09-30 | Not split by product $289.46M 100.00% | $289.46M |
| 2024-06-30 | Not split by product $306.10M 100.00% | $306.10M |
| 2024-03-31 | Not split by product $303.43M 100.00% | $303.43M |
| 2023-12-31 | Not split by product $272.60M 100.00% | $272.60M |
| 2023-09-30 | Not split by product $276.94M 100.00% | $276.94M |
| 2023-06-30 | Not split by product $301.32M 100.00% | $301.32M |
| 2023-03-31 | Not split by product $294.15M 100.00% | $294.15M |
| 2022-12-31 | Not split by product $271.58M 100.00% | $271.58M |
| 2022-09-30 | Not split by product $269.65M 100.00% | $269.65M |
| 2022-06-30 | Not split by product $288.23M 100.00% | $288.23M |
| 2022-03-31 | Not split by product $290.38M 100.00% | $290.38M |
| 2021-12-31 | Not split by product $269.28M 100.00% | $269.28M |
| 2021-09-30 | Not split by product $257.72M 100.00% | $257.72M |
| 2021-06-30 | Not split by product $259.03M 100.00% | $259.03M |
| 2021-03-31 | Not split by product $243.55M 100.00% | $243.55M |
| 2020-12-31 | Not split by product $224.25M 100.00% | $224.25M |
| 2020-09-30 | Not split by product $204.20M 100.00% | $204.20M |
| 2020-06-30 | Not split by product $175.83M 100.00% | $175.83M |
| 2020-03-31 | Not split by product $194.68M 100.00% | $194.68M |
| 2019-12-31 | Not split by product $184.93M 100.00% | $184.93M |
| 2019-09-30 | Not split by product $183.24M 100.00% | $183.24M |
| 2019-06-30 | Not split by product $191.66M 100.00% | $191.66M |
| 2019-03-31 | Not split by product $184.86M 100.00% | $184.86M |
| 2018-12-31 | Not split by product $174.51M 100.00% | $174.51M |
| 2018-09-30 | Not split by product $162.97M 100.00% | $162.97M |
| 2018-06-30 | Not split by product $180.25M 100.00% | $180.25M |
| 2018-03-31 | Not split by product $163.97M 100.00% | $163.97M |
| 2017-12-31 | Not split by product $154.15M 100.00% | $154.15M |
| 2017-09-30 | Not split by product $144.61M 100.00% | $144.61M |
| 2017-06-30 | Not split by product $156.58M 100.00% | $156.58M |
| 2017-03-31 | Not split by product $144.04M 100.00% | $144.04M |
| 2016-12-31 | Not split by product $131.81M 100.00% | $131.81M |
| 2016-09-30 | Not split by product $130.58M 100.00% | $130.58M |
| 2016-06-30 | Not split by product $134.76M 100.00% | $134.76M |
| 2016-03-31 | Not split by product $130.97M 100.00% | $130.97M |
| 2015-12-31 | Not split by product $120.91M 100.00% | $120.91M |
| 2015-09-30 | Not split by product $112.38M 100.00% | $112.38M |
| 2015-06-30 | Not split by product $117.66M 100.00% | $117.66M |
| 2015-03-31 | Not split by product $114.16M 100.00% | $114.16M |
| 2014-12-31 | Not split by product $111.95M 100.00% | $111.95M |
| 2014-09-30 | Not split by product $108.48M 100.00% | $108.48M |
| 2014-06-30 | Not split by product $92.52M 100.00% | $92.52M |
| 2014-03-31 | Not split by product $95.56M 100.00% | $95.56M |
| 2013-12-31 | Not split by product $84.02M 100.00% | $84.02M |
| 2013-09-30 | Not split by product $85.67M 100.00% | $85.67M |
| 2013-06-30 | Not split by product $79.47M 100.00% | $79.47M |
| 2013-03-31 | Not split by product $80.99M 100.00% | $80.99M |
| 2012-12-31 | Not split by product $75.08M 100.00% | $75.08M |
| 2012-09-30 | Not split by product $75.03M 100.00% | $75.03M |
| 2012-06-30 | Not split by product $78.68M 100.00% | $78.68M |
| 2012-03-31 | Not split by product $83.62M 100.00% | $83.62M |
| 2011-12-31 | Not split by product $74.66M 100.00% | $74.66M |
| 2011-09-30 | Not split by product $77.60M 100.00% | $77.60M |
| 2011-06-30 | Not split by product $78.04M 100.00% | $78.04M |
| 2011-03-31 | Not split by product $76.27M 100.00% | $76.27M |
| 2010-12-31 | Not split by product $67.71M 100.00% | $67.71M |
| 2010-09-30 | Not split by product $67.94M 100.00% | $67.94M |
| 2010-06-30 | Not split by product $66.71M 100.00% | $66.71M |
| 2010-03-31 | Not split by product $70.28M 100.00% | $70.28M |
| 2009-12-31 | Not split by product $65.52M 100.00% | $65.52M |
| 2009-09-30 | Not split by product $66.53M 100.00% | $66.53M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |